Data as of 3:35pm ET
| +0.07 / +1.27%|
The 3 analysts offering 12-month price forecasts for Ocera Therapeutics Inc have a median target of 17.00, with a high estimate of 26.00 and a low estimate of 15.00. The median estimate represents a +204.66% increase from the last price of 5.58.
The current consensus among 4 polled investment analysts is to Buy stock in Ocera Therapeutics Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.